• LAST PRICE
    17.0300
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    16.5000/ 1
  • Ask / Lots
    21.3500/ 1
  • Open / Previous Close
    0.0000 / 17.0300
  • Day Range
    ---
  • 52 Week Range
    Low 11.8300
    High 28.8000
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 17.5
TimeVolumeRGNX
09:32 ET811417.46
09:34 ET90017.465
09:36 ET20017.725
09:41 ET100017.615
09:43 ET10017.53
09:45 ET110017.52
09:48 ET90017.63
09:54 ET150017.62
09:56 ET20017.63
10:01 ET32017.59
10:03 ET85417.52
10:06 ET10017.46
10:08 ET251017.33
10:10 ET315717.415
10:14 ET30017.4489
10:15 ET10017.48
10:17 ET82517.55
10:24 ET52017.54
10:26 ET42417.55
10:28 ET30017.6
10:30 ET50017.6
10:32 ET156517.6
10:33 ET128317.57
10:35 ET60017.575
10:37 ET30017.56
10:39 ET10017.58
10:42 ET20017.6
10:44 ET40017.54
10:46 ET20017.49
10:48 ET10017.46
10:50 ET957317.525
10:51 ET106317.51
10:53 ET260017.465
10:55 ET90017.47
10:57 ET10017.455
11:00 ET40017.455
11:02 ET196317.46
11:04 ET100017.46
11:06 ET10017.45
11:08 ET82817.445
11:09 ET10017.47
11:11 ET20017.47
11:13 ET209517.47
11:15 ET60017.49
11:18 ET10017.48
11:20 ET183017.44
11:22 ET70017.365
11:24 ET10017.36
11:27 ET30017.31
11:29 ET30017.31
11:31 ET10017.305
11:33 ET191217.29
11:36 ET10017.3
11:38 ET155017.35
11:40 ET20017.365
11:42 ET20017.37
11:44 ET53117.395
11:45 ET10017.395
11:47 ET20017.3975
11:49 ET20017.39
11:51 ET22617.39
11:54 ET87717.39
11:56 ET22717.41
11:58 ET10017.415
12:00 ET424817.47
12:02 ET30017.475
12:03 ET152717.475
12:05 ET148217.475
12:07 ET151817.455
12:09 ET10017.455
12:12 ET120517.49
12:14 ET43017.49
12:16 ET218917.405
12:18 ET10017.41
12:20 ET10017.41
12:21 ET43117.45
12:23 ET325717.395
12:27 ET10017.37
12:30 ET69917.3916
12:32 ET42917.415
12:34 ET20017.37
12:36 ET12417.385
12:38 ET94317.37
12:39 ET10017.37
12:41 ET23217.375
12:43 ET212617.3501
12:45 ET20017.34
12:48 ET30017.3
12:50 ET210417.37
12:54 ET72917.395
12:56 ET44017.41
12:59 ET280017.43
01:01 ET119317.46
01:03 ET461317.42
01:08 ET10017.45
01:10 ET32317.445
01:12 ET10017.43
01:14 ET32117.45
01:15 ET11417.4684
01:17 ET43217.48
01:19 ET10017.45
01:21 ET49017.46
01:26 ET66517.455
01:30 ET782617.48
01:32 ET50017.49
01:33 ET20017.48
01:35 ET72517.46
01:37 ET80017.485
01:39 ET30017.48
01:42 ET436317.455
01:44 ET148217.44
01:46 ET42217.455
01:48 ET20017.44
01:51 ET30017.45
01:53 ET30017.43
01:55 ET60017.46
02:00 ET10017.47
02:02 ET92317.46
02:06 ET20017.46
02:09 ET20017.45
02:11 ET90017.4
02:13 ET133717.41
02:15 ET56917.39
02:18 ET159117.38
02:20 ET10017.39
02:22 ET10017.38
02:24 ET10017.39
02:29 ET40017.382
02:31 ET210017.32
02:33 ET81717.305
02:38 ET10517.31
02:40 ET100017.33
02:42 ET80017.34
02:44 ET159817.355
02:45 ET10017.355
02:47 ET112617.345
02:49 ET10017.35
02:51 ET291017.37
02:54 ET172617.32
02:56 ET117317.3
02:58 ET42817.335
03:00 ET10017.335
03:02 ET43117.31
03:03 ET110017.25
03:07 ET133417.19
03:09 ET20017.21
03:12 ET42117.18
03:14 ET52717.17
03:16 ET81917.165
03:18 ET228217.2
03:21 ET43817.195
03:23 ET181217.18
03:27 ET80017.18
03:30 ET110617.1793
03:32 ET32917.165
03:34 ET174217.18
03:36 ET647117.215
03:38 ET98817.24
03:39 ET186717.23
03:41 ET60017.24
03:43 ET159017.1915
03:45 ET126117.17
03:48 ET60017.16
03:50 ET118217.14
03:52 ET120017.09
03:54 ET200717.1
03:56 ET842617.01
03:57 ET435017.01
03:59 ET1094217.03
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRGNX
Regenxbio Inc
835.2M
-2.8x
---
United StatesNRIX
Nurix Therapeutics Inc
835.0M
-5.3x
---
United StatesSAGE
SAGE Therapeutics Inc
755.5M
-1.4x
---
United StatesYMAB
Y-mAbs Therapeutics Inc
661.5M
-30.8x
---
United StatesZYME
Zymeworks Inc
624.5M
-5.1x
---
United StatesPRTA
Prothena Corporation PLC
1.1B
-7.5x
---
As of 2024-04-18

Company Information

REGENXBIO Inc. is a clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. The Company has developed a pipeline of gene therapy programs using its proprietary adeno-associated virus (AAV) gene therapy delivery platform (NAV Technology Platform) to address genetic diseases. The Company is focused on its internal development pipeline in three areas: retinal, neuromuscular and neurodegenerative diseases. Its investigational AAV therapeutics include ABBV-RGX-314, RGX-202 and RGX-121. It is developing ABBV-RGX-314 in collaboration with AbbVie to treat large patient populations impacted by wet age-related macular degeneration, diabetic retinopathy (DR) and other chronic retinal diseases characterized by loss of vision. It is developing RGX-202 to treat Duchenne muscular dystrophy (Duchenne). The Company is developing RGX-121 to treat Mucopolysaccharidosis type II (MPS II), a progressive, neurodegenerative lysosomal storage disorder.

Contact Information

Headquarters
9804 Medical Center DriveROCKVILLE, MD, United States 20850
Phone
240-552-8181
Fax
302-655-5049

Executives

Chairman of the Board
Allan Fox
President, Chief Executive Officer, Director
Kenneth Mills
Chief Financial Officer, Executive Vice President
Vittal Vasista
Chief Operating Officer, Executive Vice President
Curran Simpson
Executive Vice President, Chief Scientific Officer
Olivier Danos

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$835.2M
Revenue (TTM)
$90.2M
Shares Outstanding
49.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.35
EPS
$-6.03
Book Value
$7.08
P/E Ratio
-2.8x
Price/Sales (TTM)
9.3
Price/Cash Flow (TTM)
---
Operating Margin
-297.12%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.